Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




TB Blood Test Could Detect Millions of Silent Spreaders

By LabMedica International staff writers
Posted on 26 Mar 2024

Tuberculosis (TB) is the world's deadliest infectious disease, claiming over one million lives annually as reported by the World Health Organization. More...

TB's transmission occurs through the air when an infected person coughs or sneezes, releasing minute droplets that can affect not just the lungs but any body part. The fight against TB's spread is significantly hampered by the current testing methods, which are not only slow but also depend on specialized equipment and laboratory settings. Consequently, nearly three million TB cases went undetected last year, predominantly in developing nations, with a third of infected individuals remaining undiagnosed and, thus, contagious. In a significant development, scientists have advanced towards developing a blood test capable of detecting millions of people who are unknowingly transmitting TB.

In a pioneering study conducted by the University of Southampton (Southampton, UK), researchers have identified a specific group of biological markers present in high levels in individuals who are infectious. This discovery holds the promise of a simple diagnostic test capable of identifying and halting the spread of the disease, which affects an estimated 10 million people each year. Collaborating with international experts, these scientists performed the most detailed examination of blood markers associated with this bacterial infection. Utilizing an innovative approach, they identified six proteins that show a high degree of accuracy in identifying individuals with active TB.

The research team analyzed blood proteins from people with active TB located in Africa and South America, comparing these biomarkers against those found in healthy individuals and others with lung infections. They discovered 118 proteins that varied markedly between these groups. From these, they narrowed down to six proteins which they found could be used to effectively differentiate individuals with contagious TB from those who are healthy or have other lung ailments. This breakthrough finding paves the way for the development of a TB test which could be as simple as the lateral flow tests widely used during the recent pandemic.

“In our study, we combined a new measurement technique with deep mathematical analysis to identify these six new markers of TB disease,” said Dr. Hannah Schiff, a respiratory expert at Southampton. “It could lead to a transformative alternative to diagnosing the condition – a simple test that detects proteins in the bloodstream whose levels differ between people with TB, healthy individuals, and those suffering from other respiratory illnesses.”

Related Links:
University of Southampton


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Immunofluorescence Analyzer
IFA System
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.